Package 60219-1677-1

{"route": ["ORAL"], "spl_id": "4c4923d9-915c-441a-90ee-fca641301d6e", "openfda": {"upc": ["0360219167711"], "unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["b4ef805f-9fc3-47f7-b1f7-328c54970e5d"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (60219-1677-1)", "package_ndc": "60219-1677-1", "marketing_start_date": "20211025"}], "brand_name": "chlordiazepoxide hydrochloride and clidinium bromide", "product_id": "60219-1677_4c4923d9-915c-441a-90ee-fca641301d6e", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "60219-1677", "dea_schedule": "CIV", "generic_name": "chlordiazepoxide hydrochloride and clidinium bromide", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "chlordiazepoxide hydrochloride and clidinium bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA215555", "marketing_category": "ANDA", "marketing_start_date": "20211025", "listing_expiration_date": "20261231"}